Easton Pharmaceuticals (EAPH) Stock Statistics & Valuation Metrics

Easton Pharmaceuticals has a market cap or net worth of $933.00. The enterprise value is ―.

Easton Pharmaceuticals has 932,729,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Easton Pharmaceuticals’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Easton Pharmaceuticals is 0.00. Easton Pharmaceuticals’s PEG ratio is 0.00.

In the last 12 months, Easton Pharmaceuticals had revenue of 0.00 and earned 0.00 in profits. Earnings per share was 0.00.

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.

Easton Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―

Easton Pharmaceuticals upcoming earnings date is Jun 13, 2019, TBA Not Confirmed.

Easton Pharmaceuticals as a current ratio of 0.00, with Debt / Equity ratio of 0.00%

In the past 12 months, Easton Pharmaceuticals has paid 0.00 in taxes.

Easton Pharmaceuticals EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Easton Pharmaceuticals has $0.00 in cash and marketable securities with $0.00 in debt, giving a net cash position of $0.00 billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Easton Pharmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is ―